Compass Therapeutics, Inc. logo CMPX - Compass Therapeutics, Inc.

NEXT EARNINGS: Feb 26, 2026 (in 1 day) EPS Est: $-0.10
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 13
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $11.40 DETAILS
HIGH: $15.00
LOW: $9.00
MEDIAN: $10.00
CONSENSUS: $11.40
UPSIDE: 90.00%
Market Cap: 829.72M
Volume: 2,005,852
Avg Volume: 2,141,123
52 Week Range: 1.33-6.88
Sector: Healthcare
Industry: Biotechnology
Beta: 1.27
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 35
IPO Date: 2021-04-05
EPS (TTM): -0.36
P/E Ratio: -4.03
Revenue (TTM): 850,000
Total Assets: 140.40M
Total Debt: 6.63M
Cash & Equiv: 43.48M
Rev Growth (5Y): N/A
EPS Growth (5Y): N/A
FCF Growth (5Y): N/A
ROCE: -43.1%
Debt/Equity: 0.05

Earnings History

Date EPS Actual EPS Est EPS Surprise Rev Actual Rev Est Rev Surprise
2025-11-05 $-0.08 $-0.14 +42.9%
2025-08-11 $-0.14 $-0.13 -7.7%
2025-05-08 $-0.12 $-0.12 0.0%
2025-02-27 $-0.11 $-0.10 -10.0%
2024-11-12 $-0.08 $-0.11 +27.3%
2024-08-12 $-0.10 $-0.10 0.0% $850000
2024-05-13 $-0.08 $-0.11 +27.3%
2024-03-21 $-0.11 $-0.09 -22.2% $2.8M

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019 2018
Revenue 850,000 0 0 0 0 0 0
Net Income (49.38M) (42.49M) (39.23M) (82.18M) (29.50M) (34.74M) (38.29M)
EPS -0.36 -0.33 -0.35 -1.31 -0.52 -0.67 -7.66
Total Assets 140.40M 156.88M 199.65M 153.76M 51.91M 30.38M 64.62M
Total Debt 6.63M 1.73M 2.94M 4.04M 9.33M 14.87M 14.75M
Cash & Equivalents 43.48M 24.23M 34.95M 144.51M 47.08M 25.30M 57.51M
Operating Cash Flow (44.85M) (40.62M) (34.12M) (19.67M) (26.80M) (31.74M) (33.68M)
Free Cash Flow (44.90M) (40.65M) (34.34M) (21.23M) (26.91M) (32.21M) (35.70M)
FCF per Share -0.33 -0.32 -0.33 -0.34 -0.48 -0.62 -7.14
Book Value 125.23M 148.54M 181.64M 140.08M 39.95M (118.60M) (84.77M)
Cash & ST Investments 126.72M 152.46M 186.61M 144.51M 47.08M 25.30M 57.51M
ROC Equity -0.39 -0.29 -0.22 -0.59 -0.74 N/A N/A